Under overexpression of PKCα, PKC activity increased 12-fold in response to the combination of treatment with quercetin and anti-CD95 for over 12 hours in a HPB acute lymphoblastic leukemia cell line. This evidence concerns the gene PRRT2 and acute lymphoblastic leukemia.